Lolli C, Verde A, Degli Esposti L, Acciai V, Brigido A, Proietti E, Scagliarini S. Cabozantinib use in second or subsequent line of treatment in renal cell carcinoma: an analysis of Italian administrative databases. Grhta [Internet]. 2024 Jul. 3 [cited 2024 Nov. 21];11(1):154-60. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2892